Definium Therapeutics (DFTX) Stock Research

Thursday

Definium Therapeutics reports Q2 EPS ($1.44), consensus (53c)

DFTX

Aug 6, 4:11 PM

Definium Therapeutics, Inc. options imply 14.8% move in share price post-earnings

DFTX

Aug 6, 3:19 PM

Over a week ago

Definium Therapeutics, Inc. options imply 11.0% move in share price post-earnings

DFTX

Jul 30, 3:25 PM

Psychedelic: Clearmind reports safety findings for CMND-100

Jul 30, 10:43 AM

Definium Therapeutics initiated with bullish view at Wells Fargo, here's why

DFTX

Jul 27, 5:21 AM

Definium Therapeutics price target raised by $25 at Piper Sandler, here's why

DFTX

Jul 24, 6:53 AM

AtaiBeckley downgraded to Hold from Buy at JonesResearch

Jul 16, 4:19 PM

FDA announces availability of final guidance for psychedelic drug research

Jul 15, 11:10 AM

Definium Therapeutics announces results from healthcare claims study in GAD

DFTX

Jul 14, 7:05 AM

VA, HHS sign MOU to improve cooperation on psychedelic drug trials

Jul 13, 3:39 PM

Jefferies says guidance suggests FDA receptive to helping psychedelic sponsors

Jul 13, 1:10 PM

Psychedelic: Compass Pathways reports six-month data for psilocybin drug

Jul 9, 9:48 AM

Definium Therapeutics price target raised by $30 at Stifel, here's why

DFTX

Jul 8, 7:05 AM

Psychedelic: Helus Pharma reports FY26 financial results

Jul 2, 9:56 AM

Definium Therapeutics price target lowered by $2 at Canaccord, here's why

DFTX

Jun 30, 7:04 AM

Psychedelic: Definium soars on study results for LSD-based depression treatment

Jun 25, 10:14 AM

Definium Therapeutics rises 21.8%

DFTX

Jun 24, 12:00 PM

Definium Therapeutics rises 17.7%

DFTX

Jun 24, 10:01 AM

Definium Therapeutics 20.6M share Secondary priced at $34.00

DFTX

Jun 24, 6:18 AM

Definium Therapeutics price target raised by $13 at JonesResearch, here's why

DFTX

Jun 24, 4:37 AM

Definium Therapeutics price target raised by $20 at Baird, here's why

DFTX

Jun 23, 6:20 AM

Closing Bell Movers: Avis Budget jumps over 6% on Pentwater settlement

Jun 22, 7:40 PM

What You Missed On Wall Street On Monday

+33

Jun 22, 4:11 PM

Definium Therapeutics offers to sell $500M in common stock

DFTX

Jun 22, 4:06 PM

Canaccord ups Definium Therapeutics target to $60, calls DT120 'solid contender'

DFTX

Jun 22, 2:03 PM